SUVEN LIFE SCIENCES
Back to Income Statement
|
SUVEN LIFE SCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-105 Cr | ₹-118 Cr | ₹-122 Cr | ₹-72 Cr | ₹-94 Cr |
What is the latest Consolidated Net Profit of SUVEN LIFE SCIENCES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹-105 Cr |
Mar2023 | ₹-118 Cr |
Mar2022 | ₹-122 Cr |
Mar2021 | ₹-72 Cr |
Mar2020 | ₹-94 Cr |
How is Consolidated Net Profit of SUVEN LIFE SCIENCES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-105 Cr | Negative | |
Mar2023 | ₹-118 Cr | Negative | |
Mar2022 | ₹-122 Cr | Negative | |
Mar2021 | ₹-72 Cr | Negative | |
Mar2020 | ₹-94 Cr | - |
Compare Consolidated Net Profit of peers of SUVEN LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN LIFE SCIENCES | ₹2,622.7 Cr | -8.8% | -7.6% | 18% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,931.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,322.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,116.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
SUVEN LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN LIFE SCIENCES | -8.8% |
-7.6% |
18% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses